The Nogo-66 receptor family in the intact and diseased CNS. - sprookjes - yvandenbroek - TriplyDB

The Nogo-66 receptor family in the intact and diseased CNS.

The Nogo-66 receptor family in the intact and diseased CNS.

http://www.wikidata.org/entity/Q37981918

about

Characterizing autism spectrum disorders by key biochemical pathways.The Role of Astrocytes in Multiple Sclerosis Progression Agenesis of the corpus callosum in Nogo receptor deficient mice Genome-wide meta-analysis identifies new susceptibility loci for migraine.Two monoclonal antibodies recognising aa 634-668 and aa 1026-1055 of NogoA enhance axon extension and branching in cultured neurons.Impacts of phosphatase and tensin homology deleted on chromosome ten (PTEN)-inhibiting chitosan scaffold on growth and differentiation of neural stem cells.Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.Function of Nogo-A/Nogo-A receptor in Alzheimer's disease.Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis.Polymorphism within a Neuronal Activity-Dependent Enhancer of NgR1 Is Associated with Corpus Callosum Morphology in Humans.Regulation and effects of GDF-15 in the retina following optic nerve crush.p75NTR and TROY: Uncharted Roles of Nogo Receptor Complex in Experimental Autoimmune Encephalomyelitis.Nogo-A does not inhibit retinal axon regeneration in the lizard Gallotia galloti.SCIRR39 promotes differentiation of oligodendrocyte precursor cells and regulates expression of myelin-associated inhibitory factors.A Nogo-Like Signaling Perspective from Birth to Adulthood and in Old Age: Brain Expression Patterns of Ligands, Receptors and Modulators.

P2860

Q26781645-7734EA02-FDDB-45A3-B51F-82A8D8FE7AE9 Q26782843-6FF1EABB-374F-4B69-9B38-BB32BC2C6C3D Q28593846-630BFA20-C794-4B18-9A36-5ABEBAE800D9 Q29417021-0C8B9EAE-1F55-42ED-A74F-EA56A834FAC8 Q35095421-CE089B2A-6B3B-4F9F-AB7C-D637CD753C11 Q36183618-E00F718D-B6E5-476B-BAC3-25C1921FE2AF Q37325616-2DB0C4CF-837F-40E9-98AC-E1A039647194 Q38366946-A7157C80-9E24-42E7-B0A7-554156C5A8D6 Q39866746-F0371071-1568-43C8-8C1B-02EAD3C79D0C Q41289413-77B89634-A85A-4075-B58B-F76DD8823C08 Q44539786-0CC9FA0C-8F97-4F7D-A1D6-B5320449326E Q48320605-4E3F9C9C-A8D9-41EE-9C3E-0C4A612ABEC9 Q51519839-BD9DB328-BF3D-4DBA-B33C-62E1F3BC0EF9 Q53118748-D8C44FA1-6C87-4F43-AD16-86D8D0392060 Q55216448-2A326BC6-782F-45A2-A27D-851744504697

P2860

The Nogo-66 receptor family in the intact and diseased CNS.

http://www.wikidata.org/entity/Q37981918

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The Nogo-66 receptor family in the intact and diseased CNS.

@en

The Nogo-66 receptor family in the intact and diseased CNS.

@nl

type

label

The Nogo-66 receptor family in the intact and diseased CNS.

@en

The Nogo-66 receptor family in the intact and diseased CNS.

@nl

prefLabel

The Nogo-66 receptor family in the intact and diseased CNS.

@en

The Nogo-66 receptor family in the intact and diseased CNS.

@nl

P1433

Q37981918-7F4B8C62-A737-4E1F-AF21-D808C4F2917C

P1476

Q37981918-FBB40B0C-0692-4B46-B43C-16BEA1363236

P2093

Q37981918-0865E27C-3166-4F7F-8CC5-E3D3D1CA92D4

Q37981918-2BF216E3-0567-4E8E-916E-9DA2552B4FC4

Q37981918-81EB7C7D-B628-41DF-98A5-55099015A59D

P2860

Q37981918-005D7E1E-E51A-4D07-BF78-66EE8A6D6B40

Q37981918-0533F993-F740-4627-B288-134F54749119

Q37981918-07D48C93-BE7B-4163-B767-D153F63E8C0D

Q37981918-08440511-C6BF-4C2E-8599-5C7B7D709EEF

Q37981918-0BF498DF-A6AC-47D3-88F3-063C5B99DA9E

Q37981918-0C2733BB-B3EF-41A9-8E70-C7EC9396F724

Q37981918-0D9637D9-9968-4F9F-A03F-AE5979A7394A

Q37981918-0F57E872-1570-4196-ABB7-D47B3C262492

Q37981918-1B52D35E-DB9D-4546-A264-348662EEC90C

Q37981918-1C62AE17-4FC3-4033-9CC3-B443C84B0BB9

P2888

Q37981918-752F75DB-6EB4-439C-9E66-F3F353D87F9B

P304

Q37981918-D3A7C5F0-C136-4384-98D3-D5467EBCFE24

P31

Q37981918-3058F3A6-D9F7-468F-B1B6-A29B77FBFAD0

P356

Q37981918-0A5B0FA5-AC6D-4A8D-8B21-7A12A9C42DD3

P433

Q37981918-DF612D9A-9B13-408A-86B6-D011994ACC51

P478

Q37981918-2398AEED-091B-41EF-8CC9-2A57A39F9446

P577

Q37981918-BA00FA37-EB10-48D4-AE45-1F64FD8C6706

P698

Q37981918-19D6607B-84A9-4742-826A-0F08F239B62B

P356

S00441-012-1332-9

P1433

Cell and Tissue Research

P1476

The Nogo-66 receptor family in the intact and diseased CNS.

@en

P2093

Bastian E Baeumer

http://www.w3.org/2001/XMLSchema#string

Christine E Bandtlow

http://www.w3.org/2001/XMLSchema#string

Sarah C Borrie

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's Disease

Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration

Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity

Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor

Two novel mammalian Nogo receptor homologs differentially expressed in the central and peripheral nervous systems

LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition

Genetic variation in the 22q11 locus and susceptibility to schizophrenia

Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins

P2888

s00441-012-1332-9

P304

105-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00441-012-1332-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22311207

http://www.w3.org/2001/XMLSchema#string